CN110903189B - Synthesis method of chiral 2-aryl propionate - Google Patents

Synthesis method of chiral 2-aryl propionate Download PDF

Info

Publication number
CN110903189B
CN110903189B CN201911258281.XA CN201911258281A CN110903189B CN 110903189 B CN110903189 B CN 110903189B CN 201911258281 A CN201911258281 A CN 201911258281A CN 110903189 B CN110903189 B CN 110903189B
Authority
CN
China
Prior art keywords
sih
chiral
reaction
aryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911258281.XA
Other languages
Chinese (zh)
Other versions
CN110903189A (en
Inventor
李争宁
赵晓媛
白瑞
李泉城
姜岚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University
Original Assignee
Dalian University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University filed Critical Dalian University
Priority to CN201911258281.XA priority Critical patent/CN110903189B/en
Publication of CN110903189A publication Critical patent/CN110903189A/en
Application granted granted Critical
Publication of CN110903189B publication Critical patent/CN110903189B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/303Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the technical field of chemical synthesis, relates to a synthesis method of chiral 2-aryl propionate, and particularly relates to enantioselective synthesis of 2-aryl propionate. The invention relates to a copper salt, a chiral phosphine ligand, a hydrosilicon compound (calculated as SiH), R1Adding OH and 2-aryl acrylate into a reaction bottle according to a certain proportion, reacting in a reaction solvent at-50-40 ℃ for 0.25-6h, and after the reaction is finished, hydrolyzing, separating liquid, extracting, washing, drying and carrying out column chromatography to obtain the target compound. Compared with the prior art, the invention adopts a Cu catalytic system to reduce the 2-aryl acrylate, and the catalyst Cu compound has low price, thereby breaking throughHydrogen high pressure reduction and the limitation of noble metal catalysts. The chiral 2-aryl propionic acid can be obtained by simple hydrolysis reaction of the product, wherein partial product is the effective component of the existing medicines on the market such as ibuprofen and naproxen.

Description

Synthesis method of chiral 2-aryl propionate
Technical Field
The invention belongs to the technical field of chemical synthesis, and relates to enantioselective synthesis of 2-aryl propionate.
Background
2-aryl propionic acids are common analgesic and anti-inflammatory drugs. Wherein ibuprofen (ibuprofofen) is OTC non-steroidal anti-inflammatory drug[1]It is widely used for treating headache, neuralgia, rheumatic arthritis, rheumatoid arthritis and other diseases. The effective component is (S) - (+) -ibuprofen, and the (R) - (-) -ibuprofen isomer is ineffective. Naproxen (Naproxen) is PG synthetase inhibitor, has effects of relieving inflammation, relieving fever and relieving pain for various acute pains, has positive curative effects for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, chronic degenerative diseases of motion system, light and moderate pains and the like, and is used for relieving migraine, tension headache, postoperative pain and pains related to various gynecological operations[2]. Clinical results showed that the biological activity of (S) - (+) -naproxen was 28 times higher than that of (R) - (-) -naproxen. The structures of (S) - (+) -ibuprofen and (S) - (+) -naproxen are shown in FIG. 1.
The synthesis of racemic ibuprofen includes Boots method and BHC method. The Boots method uses isobutyl benzene as raw material, and produces isobutyl acetophenone by Friedel-crafts reaction, and then produces ibuprofen by Darzens reaction and oxidation reaction[3]. The method has the problems of long route, poor atom economy and high raw material cost, and has high requirement on the corrosion resistance of equipment; BHC method is characterized by that it utilizes 1- (4-isobutyl phenyl) ethanone to make reduction and alcohol carbonylation reaction to synthesize ibuprofen[4]Wherein the carbonylation reaction adopts Pd (PPh)3)2Cl2Used as a catalyst. The method has good atom economy, but has the problems of high cost and toxicity of the noble metal Pd, high pressure for reaction and the like. The synthesis method and the existing problems of naproxen are similar to those of ibuprofen.
Chiral (S) - (+) -ibuprofen and (S) - (+) -naproxen are mainly separated by racemizationAnd (3) resolving ibuprofen and naproxen to obtain the ibuprofen compound. The compounds are prepared by adopting an asymmetric catalysis method, so that high-atom economic reaction can be realized, the generation of ineffective isomers and the influence on a human body or the environment are reduced, and the method has a good industrial application prospect. The main method at present is the asymmetric hydroformylation of aryl ethylene catalyzed by transition metals Rh, Ru and Pd[5]Or by hydrogen esterification[6]Asymmetric carbonylation of 1-arylethanols[7]Or asymmetric hydrogenation of 2-arylacrylic acids[8 , 9]. However, the transition metals used in the catalysts are expensive and require high pressure, which limits their industrial application.
Reference to the literature
1.Kantor,T.G.,Ibuprofen.Annals ofinternal medicine 1979,91(6),877-82.
2.Todd,P.A.;Clissold,S.P.,Naproxen.A reappraisal of its pharmacology,and therapeutic use in rheumatic diseases andpain states.Drugs 1990,40(1),91-137.
3. In Fengli, Zhao Yu Liang, jin Zi Lin, ibuprofen synthesis of green progress organic chemistry, 2003,11,1198-
4.Sheldon,R.A.Chemtech 1994,24,38.
5.Francio,G.;Leitner,W.,Highly regio-and enantio-selective rhodium-catalysed asymmetric hydroformylation without organic solvents.Chem.Commun.1999,(17),1663-1664.
6.Cometti,G.;Chiusoli,G.P.J.Organomet.Chem.1982,236,C31.
7.Xie,B.H.;Xia,C.G.;Lu,S.J.;Chen,K.J.;Kou,Y.;Yin,Y.Q.,The first asymmetric carbonylation of 1-(6'-methoxy-2'-naphthyl)ethanol to the methyl ester of(S)-naproxen.Tetrahedron Lett.1998,39(40),7365-7368.
8.Monteiro,A.L.;Zinn,F.K.;DeSouza,R.F.;Dupont,J.,Asymmetric hydrogenation of2-arylacrylic acids catalyzed by immobilized Ru-BINAP complex in1-n-butyl-3-methylimidazolium tetrafluoroborate molten salt.Tetrahedron-Asym.1997,8(2),177-179.
9. Zhang Shumo, Chencaiyou, chiral bisphosphine ligands and their use in asymmetric hydrogenation and related reactions, Chinese patent application No. 201510765575.7,2015.11.11.
Disclosure of Invention
Aiming at the problems, the invention uses cheap copper as a catalyst and silane as a reducing agent to reduce 2-aryl acrylate in the presence of chiral phosphine ligand to generate chiral 2-aryl propionate. The chiral 2-aryl propionic acid can be obtained by simply hydrolyzing the target compound. The method has the advantages of mild condition, simple operation, environmental protection and certain chiral selectivity. The 2- (4-methoxyphenyl) propionate and the like obtained by the method can be widely applied to the synthesis of the two medicines.
The synthesis method comprises the following steps: copper salt, chiral phosphine ligand, hydrosilicon compound (calculated as SiH), R1Adding OH and 2-aryl acrylate into a reaction bottle according to a certain proportion, reacting in a reaction solvent at-50-40 ℃ for 0.25-6h, and after the reaction is finished, hydrolyzing, separating liquid, extracting, washing, drying and carrying out column chromatography to obtain the target compound.
The asymmetric catalytic reduction of 2-aryl acrylate to synthesize 2-aryl substituted propionate has the following reaction formula:
Figure BDA0002310905800000021
wherein Ar ═ Ph,4-F-Ph,4-Cl-Ph,4-Br-Ph,4-I-Ph,4-MeO-Ph,4-Me2CHCH2-one of Ph,1-Nap,2- (6-MeO-2-Nap),2- (6-Me-2-Nap),2- (6-Cl-2-Nap) or 2- (6-Br-2-Nap); preferably 4-Me2CHCH2-Ph and 2- (6-MeO-2-Nap). R ═ Me, Et, CF3CF2C such as n-Pr, i-Pr, n-Bu, i-Bu, t-Bu1-C5Or phenyl, benzyl, substituted phenyl with methyl or ethyl, substituted benzyl.
The copper salt, the chiral phosphine ligand, the silicon-hydrogen compound (calculated as SiH), and R1The molar ratio of OH to 2-aryl acrylate is (0.0005-0.03): (0.0005-0.03): (1-5): (0-4): 1.
the copper salt is as follows: CuF (PPh)3)3·2MeOH、Cu(OAc)2·H2O, CuX and sodium tert-butoxide or potassium tert-butoxide, wherein X is one of F, Cl and I. To avoid racemization due to excess potassium or sodium tert-butoxide, the ratio of CuX to potassium or sodium tert-butoxide is preferably from 2:1 to 1: 1. Theoretically, the ratio of the two is 1:1, wherein Cu (II) is reduced to Cu (I).
The silicon hydride is SiH or PhSiH3、Ph2SiH2、Ph3SiH、Ph2MeSiH、(SiHMe2)2O、Et3SiH、(MeO)3SiH、(SiHMe2)2NH。
Said R1OH is a primary, secondary or tertiary alcohol of 1-6 carbon atoms.
The chiral phosphine ligand is a phosphine compound L1-L6 with the following structure or an enantiomer thereof.
Figure BDA0002310905800000031
Wherein Ar' ═ Ph,3,5-Me2-Ph,3,4,5-(MeO)2-Ph,4-MeO-3,5-(t-Bu)2-Ph。
The reaction solvent is ether, aromatic hydrocarbon or alkyl halide, including ethyl ether, butyl ether, tetrahydrofuran, benzene, toluene, xylene, dichloromethane, 1, 2-dichloroethane, etc.
Compared with the prior art, the invention adopts a Cu catalytic system to reduce the 2-aryl acrylate, and the catalyst Cu compound has low price, thereby breaking through the limitations of hydrogen high-pressure reduction and noble metal catalysts. The chiral 2-aryl propionic acid can be obtained by simple hydrolysis reaction of the product, and can be used as an effective component for producing medicaments such as ibuprofen, naproxen and the like.
Drawings
FIG. 1 structures of (S) -ibuprofen and (S) -naproxen;
FIG. 2 Structure of the ligand;
FIG. 3 chiral GC spectrum of racemic methyl 2-phenylpropionate;
FIG. 4 is a chiral GC spectrum of methyl 2-phenylpropionate produced by asymmetric catalytic reaction;
FIG. 5 chiral HPLC chromatogram of racemic methyl 2- (4-isobutylphenyl) propionate;
FIG. 6 chiral HPLC chromatogram of methyl 2- (4-isobutylphenyl) propionate generated by asymmetric catalytic reaction.
FIG. 7 chiral HPLC chromatogram of methyl 2- (2-chlorophenyl) propionate generated by asymmetric catalysis;
FIG. 8 shows a chiral HPLC chromatogram of methyl 2- (4-methoxyphenyl) propionate generated by asymmetric catalytic reaction.
Detailed Description
The invention is described in more detail below with reference to specific examples, without limiting the scope of the invention. Unless otherwise specified, the experimental methods adopted by the invention are all conventional methods, and experimental equipment, materials, reagents and the like used in the experimental method can be obtained from commercial sources.
Example 1
A dry reaction flask purged with nitrogen was charged with Cu (OAc)2·H2O (2.0mg), (R, R) -L1(Ar' ═ Ph) (2.0mg), and toluene (2.0mL), and stirred at room temperature to a blue solution. To the mixture was added poly (methylhydrogensiloxane) (120. mu.L) and n-butanol (118. mu.L), and after stirring for 5min, methyl 2-phenylacrylate (0.065g) was added and further stirred for 2 h. Thereafter, saturated NH was added to the reaction mixture4Stirring the solution F (4.0mL) for 60min, separating liquid, extracting the water phase with ethyl acetate (3X 5.0mL), washing the combined organic phase with NaCl saturated solution, drying with anhydrous sodium sulfate, concentrating, and separating with a column to obtain 0.046g of methyl 2-phenylpropionate with a yield of 70%; the composition of the enantiomer is analyzed by chiral GC, ee is 8 percent, and the dominant configuration is (S) -configuration.1H NMR(500MHz,CDCl3)δ7.32–7.20(m,5H),3.66(q,J=7.1Hz,1H),3.59(s,3H),1.43(d,J=7.2Hz,3H).13C NMR(126MHz,CDCl3) δ 175.13,140.67,128.77,127.59,127.26,52.17,45.54,18.74. analytical conditions: chromatographic column beta-dex 225 chiral column, 30m × 0.25mm × 0.25 μm; the column temperature was 80 ℃. Retention time 51.6min (S-configuration), 52.7min (R-configuration).
Example 2
Dry reaction flask replaced by nitrogenAdding Cu (OAc)2·H2O (2.0mg), (R) -L2(Ar' ═ Ph) (3.0mg), and tetrahydrofuran (2.0mL) were stirred at room temperature to prepare a blue solution. Poly (methylhydrogensiloxane) (180. mu.L) and tert-butanol (140. mu.L) were added to the above system, and after stirring, methyl 2-phenylacrylate (162mg) was added, and the reaction was further stirred for 2 hours. Adding saturated NH to the reaction mixture4Stirring the Cl solution (4.0mL) for 20min, separating liquid, extracting the water phase with ethyl acetate (3X 5.0mL), washing the combined organic phase with NaCl saturated solution, drying with anhydrous sodium sulfate, concentrating, and separating with a column to obtain colorless liquid 2-phenyl methyl propionate 101mg with a yield of 62%; by chiral GC analysis, the ee value is 19%, and the dominant configuration is (S) -configuration.
Example 3
Into a dry reaction flask purged with nitrogen, Cu (OAc) was charged2·H2O (2.0mg), (S) -L3(Ar' ═ Ph) (6.1mg), and toluene (2.0mL) were stirred at room temperature to prepare a blue solution. Adding Ph to the above liquid2SiH2(184. mu.L) and neopentyl butanol (132mg) were stirred for 5min, methyl 2-phenylacrylate (152mg) was added thereto, and the reaction was continued with stirring for 2 h. Adding saturated NH to the reaction mixture4Cl solution (4.0mL), stirring for 20min, separating, extracting the aqueous phase with ethyl acetate (3X 5.0mL), washing the combined organic phases with saturated NaCl solution, drying over anhydrous sodium sulfate, concentrating, and separating with a column to obtain 2-phenylpropionic acid methyl ester (111mg, yield 72%), GC chiral analysis, ee 22%), with the predominant configuration being (S) -configuration.
Example 4
Into a dry reaction flask purged with nitrogen, Cu (OAc) was charged2·H2O(2.0mg)、(R)-L4(Ar'=4-Me-3,5-(t-Bu)2-Ph) (5.6mg), toluene (2.0mL) and stirred at room temperature to a blue solution. The temperature was reduced to-25 ℃ and poly (methylhydrogensiloxane) (120. mu.L) and tert-butanol (182. mu.L) were added to the above liquid, and after stirring for 5min, methyl 2-phenylacrylate (161mg) was added. After stirring for 2h, saturated NH was then added4Stirring Cl solution (4.0mL) for 30min, separating, extracting water phase with ethyl acetate (3 × 5.0mL), washing combined organic phase with NaCl saturated solution, drying with anhydrous sodium sulfate, concentrating, and separating with column to obtain final productThe chiral GC spectrums of the product (149mg, 91% yield, 35% ee, and the advantageous configuration being (S) -configuration, racemic body and methyl 2-phenylpropionate obtained in the present reaction are shown in FIGS. 3 and 4, respectively.
Example 5
Charging a dry reaction flask purged with nitrogen with Cu (OAc)2·H2O(2.0mg)、(R)-L4(Ar'=4-Me-3,5-(t-Bu)2-Ph) (5.6mg), xylene (2.0mL) was stirred at room temperature to a blue solution. The temperature was reduced to-30 ℃ and poly (methylhydrogensiloxane) (120. mu.L) and methanol (40. mu.L) were added to the above liquid, stirred for 5min and then added with methyl 2- (4-isobutylphenyl) -acrylate (108 mg). Stirring for 2h, and adding saturated NH4And (3) continuously stirring the Cl solution (4.0mL) for 30min, separating liquid, extracting an aqueous phase by using dimethylbenzene (3X 5.0mL), washing combined organic phases by using a NaCl saturated solution, drying the combined organic phases by using anhydrous sodium sulfate, concentrating, and separating by using a column to obtain a product (93mg, the yield is 85%, ee 53%, and the predominant configuration is (S) -configuration.1HNMR(500MHz,CDCl3)δ7.20(d,J=7.9Hz,2H),7.10(d,J=7.9Hz,2H),3.70(q,J=7.1Hz,1H),3.66(s,3H),2.44(d,J=7.2Hz,2H),1.87-1.81(m,1H),1.49(d,J=7.2Hz,3H),0.90(d,J=6.6Hz,6H).13C NMR(126MHz,CDCl3) Delta 175.39,140.70,137.85,129.49,127.25,52.15,45.16,45.14,30.33,22.54,18.77 chiral HPLC spectra of the racemate and the methyl 2- (4-isobutylphenyl) -propionate obtained in this reaction are shown in fig. 5 and 6, respectively.
Example 6
CuCl (10mg), KOBu were added to a dry Huliang bottle purged with nitrogen under nitrogent(11.2mg), chiral ligand L5(Ar' ═ Ph) (67mg), THF (2.0mL), stirred for 10min, then 1/10 was removed, another reaction flask was added, THF (2.0mL) was added, and the temperature was reduced to-50 ℃. Adding (MeO) to the reaction flask3SiH (127. mu.L) and tert-butanol (92. mu.L) were stirred for 5min, and methyl 2- (2-chlorophenyl) acrylate (92mg,0.50mmol) was added. Stirring for 1h, and adding saturated NH4Cl solution (4.0mL), stirring for 20min, separating the liquids, extracting the aqueous phase with ethyl acetate (3X 5.0mL), washing the combined organic phases with saturated NaCl solution, drying over anhydrous sodium sulfate, concentrating, and separating with a column to obtain the product (89mg, 90% yield, ee 47%).1H NMR(500MHz,CDCl3)δ7.37(dd,J=7.9,1.4Hz,1H),7.31(dd,J=7.7,1.7Hz,1H),7.28–7.23(m,1H),7.22–7.17(m,1H),4.22(q,J=7.2Hz,1H),3.68(s,3H),1.50(d,J=7.2Hz,3H).13C NMR(126MHz,CDCl3) δ 174.61,138.57,133.79,129.82,128.53,128.42,127.31,52.31,42.21, 17.75. The HPLC chromatogram of chiral OD-H column analysis of methyl 2- (2-chlorophenyl) propionate obtained in this reaction is shown in FIG. 7.
Example 7
Into a dry reaction flask purged with nitrogen, Cu (OAc) was charged2·H2O (2.0mg), (S) -L4(Ar' ═ Ph) (5.8mg), and toluene (2.0mL), and the mixture was stirred at room temperature for 10 min. Adding Ph to the above liquid2SiH2(184. mu.L) and tert-butanol (140. mu.L), and after stirring for 5min, benzyl 2-phenylacrylate (232mg) was added and the reaction was continued for 2h with stirring. Thereafter, saturated NH was added to the reaction mixture4Stirring the Cl solution (4.0mL) for 20min, separating, extracting the aqueous phase with ethyl acetate (3X 5.0mL), washing the combined organic phases with a saturated NaCl solution, drying over anhydrous sodium sulfate, concentrating, and separating with a column to obtain 169mg of benzyl 2-phenylpropionate with a yield of 72%; by HPLC analysis, ee 22%.
Example 8
CuF (PPh) was added to a dry Huliang bottle purged with nitrogen3)32MeOH (4.6mg) and (R) -L4(Ar' ═ 4-Me-3,5- (t-Bu)2-Ph) (5.6mg) and toluene (1.0mL) were stirred at room temperature for 10min, then 0.1mL of the liquid was taken out and added to another reaction flask, the temperature was reduced to-25 ℃, poly (methylhydrosiloxane) (120. mu.L) and t-butanol (182. mu.L) were added to the latter reaction flask, and after stirring for 5min, methyl 2- (4-methoxyphenyl) acrylate (97mg) was added and stirred for 5 h. Then saturated NH was added to the reaction flask4Cl solution (4.0mL), stirring for 30min, separating the liquids, extracting the aqueous phase with ethyl acetate (3X 5.0mL), washing the combined organic phases with saturated NaCl solution, drying over anhydrous sodium sulfate, concentrating, and separating with a column to obtain methyl (4-methoxyphenyl) propionate (90mg, 92% yield, ee 38%).1H NMR(500MHz,CDCl3)δ7.22(d,J=8.6Hz,1H),6.86(d,J=8.7Hz,1H),3.78(s,1H),3.72–3.66(q,J=7.2Hz,1H),3.65(s,1H),1.47(d,J=7.2Hz,3H).13C NMR(126MHz,CDCl3) δ 175.39,158.81,132.78,128.58,114.14,55.37,52.09,44.68, 18.79. The chiral HPLC chromatogram of methyl 2- (4-methoxyphenyl) propionate obtained in this reaction is shown in FIG. 8.
The above description is only for the purpose of creating a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can substitute or change the technical solution and the inventive concept of the present invention within the technical scope of the present invention.

Claims (2)

1. A method for synthesizing chiral 2-aryl propionate is characterized in that copper salt, chiral phosphine ligand, SiH (SiH) -calculated silicon hydride compound and R1Adding OH and 2-aryl acrylate into a reaction bottle according to a certain proportion, reacting in a reaction solvent at-50-40 ℃ for 0.25-6h, and after the reaction is finished, hydrolyzing, separating liquid, extracting, washing, drying and carrying out column chromatography to obtain a target compound; the copper salt, chiral phosphine ligand, SiH silicon hydride compound and R1The molar ratio of OH to 2-aryl acrylate is (0.0005-0.03): (0.0005-0.03): (1-5): (0-4): 1;
the 2-aryl acrylate
Figure FDA0003628648720000011
In (1), Ar ═ Ph,4-F-Ph,4-Cl-Ph,4-Br-Ph,4-I-Ph,4-MeO-Ph,4-Me2CHCH2-one of Ph,1-Nap,2- (6-MeO-2-Nap),2- (6-Me-2-Nap),2- (6-Cl-2-Nap) or 2- (6-Br-2-Nap);
R=CF3CF2or C1-C5Or phenyl, benzyl, substituted phenyl with methyl or ethyl, substituted benzyl;
the copper salt is as follows: CuF (PPh)3)3·2MeOH、Cu(OAc)2·H2O, CuX and sodium tert-butoxide or potassium tert-butoxide, wherein X is one of F, Cl and I;
the hydrosilicon compound is SiH、PhSiH3、Ph2SiH2、Ph3SiH、Ph2MeSiH、(SiHMe2)2O、Et3SiH、(MeO)3SiH、(SiHMe2)2NH;
Said R1OH is a primary, secondary or tertiary alcohol of 1-6 carbon atoms;
the chiral phosphine ligand is a phosphine compound L1-L6 with the following structure or an enantiomer thereof;
Figure FDA0003628648720000012
wherein Ar' ═ Ph,3,5-Me2-Ph,3,4,5-(MeO)3-Ph,4-MeO-3,5-(t-Bu)2-Ph;
The reaction solvent is ether or aromatic hydrocarbon or alkyl halide;
the ratio of CuX to potassium or sodium tert-butoxide is 2:1-1: 1.
2. The method of claim 1, wherein the reaction solvent is selected from the group consisting of ethyl ether, butyl ether, tetrahydrofuran, benzene, toluene, xylene, methylene chloride, and 1, 2-dichloroethane.
CN201911258281.XA 2019-12-10 2019-12-10 Synthesis method of chiral 2-aryl propionate Active CN110903189B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911258281.XA CN110903189B (en) 2019-12-10 2019-12-10 Synthesis method of chiral 2-aryl propionate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911258281.XA CN110903189B (en) 2019-12-10 2019-12-10 Synthesis method of chiral 2-aryl propionate

Publications (2)

Publication Number Publication Date
CN110903189A CN110903189A (en) 2020-03-24
CN110903189B true CN110903189B (en) 2022-06-21

Family

ID=69824213

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911258281.XA Active CN110903189B (en) 2019-12-10 2019-12-10 Synthesis method of chiral 2-aryl propionate

Country Status (1)

Country Link
CN (1) CN110903189B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402661A (en) * 2014-12-09 2015-03-11 江南大学 Economic and efficient method for asymmetric synthesis of R-configuration aromatic alcohol through copper salt catalysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019761A2 (en) * 1999-09-15 2001-03-22 Massachusetts Institute Of Technology Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
EP1911516B1 (en) * 2005-07-07 2014-05-14 Takasago International Corporation Homogeneous asymmetric hydrogenation process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402661A (en) * 2014-12-09 2015-03-11 江南大学 Economic and efficient method for asymmetric synthesis of R-configuration aromatic alcohol through copper salt catalysis

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Asymmetric 1,4-Hydrosilylations of α,β-Unsaturated Esters;Bruce H. Lipshutz et al;《J. Am. Chem. Soc.》;20040618;第126卷(第27期);第8352–8353页 *
Asymmetric Conjugate Reduction of α,β-Unsaturated Esters Using a Chiral Phosphine−Copper Catalyst;Daniel H. Appella et al;《J. Am. Chem. Soc.》;19990924;第121卷(第40期);第9473-9474页 *
Copper(I) Chloride;Steven H. Bertz et al;《e-EROS Encyclopedia of Reagents for Organic Synthesis》;20071231;第1-15页 *
CuH-Catalyzed Enantioselective 1,2-Reductions of α,β-Unsaturated Ketones;Moser, Ralph et al;《Journal of the American Chemical Society》;20100519;第132卷(第23期);第7852-7853页 *
CuH催化的共轭加成-分子间aldol加成多米诺反应;李增厂;《中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑》;20140115;B014-79 *
Efficient synthesis of α-substituted ethylphosphonates via CuH-catalyzed conjugate reduction of terminal alkenylphosphonate;Zhang, Li et al;《Tetrahedron Letters》;20171018;第58卷(第48期);第4538-4541页 *
Thermally accelerated asymmetric hydrosilylations using ligated copper hydride;Lipshutz, Bruce H. et al;《Canadian Journal of Chemistry》;20050611;第83卷(第6-7期);第606-614页 *
铜催化对C-C不饱和键铜氢化引发的多米诺反应;梁婷婷等;《有机化学》;20170816;第37卷;第3096-3111页 *

Also Published As

Publication number Publication date
CN110903189A (en) 2020-03-24

Similar Documents

Publication Publication Date Title
Bayeh-Romero et al. Copper hydride catalyzed enantioselective synthesis of axially chiral 1, 3-disubstituted allenes
Lu et al. Asymmetric propargylic radical cyanation enabled by dual organophotoredox and copper catalysis
Feng et al. CuH-catalyzed regio-and enantioselective hydrocarboxylation of allenes: toward carboxylic acids with acyclic quaternary centers
Echeverria et al. Synthesis, characterization and use of a new tethered Rh (III) complex in asymmetric transfer hydrogenation of ketones
Xiang et al. Synthesis of β-ketophosphonates via AgNO3-catalyzed hydration of alkynylphosphonates: a rate-enhancement effect of methanol
Liu et al. Highly enantioselective synthesis of anti aryl β-hydroxy α-amino esters via DKR transfer hydrogenation
Watanabe et al. Copper mediated defluorinative allylic alkylation of difluorohomoallyl alcohol derivatives directed to an efficient synthetic method for (Z)-fluoroalkene dipeptide isosteres
Bruffaerts et al. Zirconocene-mediated selective C–C bond cleavage of strained carbocycles: scope and mechanism
Kuwano et al. Catalytic Asymmetric Hydrogenation of. ALPHA.-(Acetamido) acrylates Using TRAP Trans-Chelating Chiral Bisphosphine Ligands. Remarkable Effects of Ligand P-Substituent and Hydrogen Pressure on Enantioselectivity.
Aitali et al. Enantioselective reduction of aromatic ketones catalysed by chiral ruthenium (II) complexes
WO1988008835A1 (en) Asymmetric hydroformylations of prochiral olefins to chiral aldehydes in high enantiomeric excess
Karagoz et al. Regio-and stereoselective synthesis of 2, 3, 5-trienoates by palladium-catalyzed alkoxycarbonylation of conjugated enyne carbonates
Lu et al. Dipeptide-derived multifunctional phosphonium salt as a catalyst to synthesize highly functionalized chiral cyclopentanes
Gao et al. Site‐and Stereoselective C (sp3)− H Borylation of Strained (Hetero) Cycloalkanols Enabled by Iridium Catalysis
Sperandio et al. Development of copper-catalyzed enantioselective decarboxylative aldolization for the preparation of perfluorinated 1, 3, 5-triols featuring supramolecular recognition properties
Mash Homochiral ketals in organic synthesis. Enantioselective synthesis and absolute configuration of (-)-chokol A
CN114805068A (en) Preparation method of chiral alpha-hydroxy-beta-keto ester compound
Lou et al. Cinchona-derived prolinamide in Brønsted acidic ionic liquids: a novel and recyclable catalytic system for asymmetric aldol reaction
Ku et al. Asymmetric synthesis of α, β-epoxysulfones via phase-transfer catalytic Darzens reaction
Inoue et al. Chiral Phebox–rhodium complexes as catalysts for asymmetric direct aldol reaction
CN110903189B (en) Synthesis method of chiral 2-aryl propionate
Cheng et al. Chiral bifunctional phosphine ligand-enabled cooperative Cu catalysis: formation of chiral α, β-butenolides via highly enantioselective γ-protonation
JP5417560B2 (en) Method for producing optically active carboxylic acid ester
Malkov et al. Synthesis of γ-functionalized allyltrichlorosilanes and their application in the asymmetric allylation of aldehydes
Cui et al. Direct aldol condensation reaction of ethyl diazoacetate with trifluoromethyl ketones

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant